Eugenia Johnson
Family · Houston, TXNPI 1699368514
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 235 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,717 and has fallen 99.1% since, to $16 in 2024. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 235 payments — averaging $19.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$882
- GSK$537
- AstraZeneca$358
- Lilly USA, LLC$242
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$236
- plus $1K from 25 others
What the payments were for
- Food & beverage$4,656100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 65 | $1,056 |
| Novo Nordisk | 40 | $882 |
| GSK | 30 | $537 |
| AstraZeneca | 12 | $358 |
| Lilly USA, LLC | 14 | $242 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $236 |
| Bayer | 7 | $170 |
| Otsuka America Pharmaceutical, Inc. | 2 | $151 |
| Amgen | 8 | $149 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $130 |
| Johnson & Johnson | 5 | $100 |
| Lundbeck LLC | 4 | $82 |
| Antares Pharma, Inc. | 4 | $75 |
| Sanofi-aventis U.S. LLC | 4 | $69 |
| Exact Sciences | 3 | $57 |
| Novartis | 3 | $55 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Pfizer | 2 | $30 |
| Halozyme Inc | 1 | $25 |
| Kaleo, Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $21 |
| Avanir Pharmaceuticals, Inc. | 1 | $21 |
| IBSA Pharma Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $14 |
| Organon | 1 | $11 |
| Genentech USA, Inc. | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,656 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 14 | $349 |
Paid to pharmacies, not to this prescriber.
Other family in Houston
- Robin BeachHouston$428K
- Sarah AguilarHouston$199K
- Margaret WhiteHouston$85K
- Cheryl HaseebHouston$42K
- Kendrick ClackHouston$28K
- David WeirDallas$959K
- April LopezMcAllen$417K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.